Matches in Nanopublications for { ?s ?p "[Interestingly, C3 treatment resulted in decreased AR binding to target genes accompanied by decreased recruitment of an AR and ?-catenin cofactor, coactivator-associated arginine methyltransferase 1 (CARM1), providing insight into the unrecognized function of ?-catenin in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP900906.RAkmOOXCl8AwEmwb25Xi605RGzw9GT85NhUrmWH06oeeo130_assertion description "[Interestingly, C3 treatment resulted in decreased AR binding to target genes accompanied by decreased recruitment of an AR and ?-catenin cofactor, coactivator-associated arginine methyltransferase 1 (CARM1), providing insight into the unrecognized function of ?-catenin in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP900906.RAkmOOXCl8AwEmwb25Xi605RGzw9GT85NhUrmWH06oeeo130_provenance.
- NP747298.RAQ3BEtSZMw8tp1jpOd64ap4i4vOGknvxoLDSrmaB2sXc130_assertion description "[Interestingly, C3 treatment resulted in decreased AR binding to target genes accompanied by decreased recruitment of an AR and ?-catenin cofactor, coactivator-associated arginine methyltransferase 1 (CARM1), providing insight into the unrecognized function of ?-catenin in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP747298.RAQ3BEtSZMw8tp1jpOd64ap4i4vOGknvxoLDSrmaB2sXc130_provenance.
- assertion description "[Interestingly, C3 treatment resulted in decreased AR binding to target genes accompanied by decreased recruitment of an AR and ?-catenin cofactor, coactivator-associated arginine methyltransferase 1 (CARM1), providing insight into the unrecognized function of ?-catenin in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Interestingly, C3 treatment resulted in decreased AR binding to target genes accompanied by decreased recruitment of an AR and ?-catenin cofactor, coactivator-associated arginine methyltransferase 1 (CARM1), providing insight into the unrecognized function of ?-catenin in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1108940.RAYY6c78QC73kJ2m5t9Utz4A29YZAul2grHp3EhIUoj88130_assertion description "[Interestingly, C3 treatment resulted in decreased AR binding to target genes accompanied by decreased recruitment of an AR and ?-catenin cofactor, coactivator-associated arginine methyltransferase 1 (CARM1), providing insight into the unrecognized function of ?-catenin in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1108940.RAYY6c78QC73kJ2m5t9Utz4A29YZAul2grHp3EhIUoj88130_provenance.
- NP844892.RAvWbA7VgCqwGDU13uCtGjEtt6tEP_b45JNz24NHzAGr8130_assertion description "[Interestingly, C3 treatment resulted in decreased AR binding to target genes accompanied by decreased recruitment of an AR and ?-catenin cofactor, coactivator-associated arginine methyltransferase 1 (CARM1), providing insight into the unrecognized function of ?-catenin in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP844892.RAvWbA7VgCqwGDU13uCtGjEtt6tEP_b45JNz24NHzAGr8130_provenance.
- NP844888.RAEQzg5SzxGG5s9jyX_2TMRwYCH0ZnDUn7vLA4wWI7SlI130_assertion description "[Interestingly, C3 treatment resulted in decreased AR binding to target genes accompanied by decreased recruitment of an AR and ?-catenin cofactor, coactivator-associated arginine methyltransferase 1 (CARM1), providing insight into the unrecognized function of ?-catenin in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP844888.RAEQzg5SzxGG5s9jyX_2TMRwYCH0ZnDUn7vLA4wWI7SlI130_provenance.
- NP1108938.RAwDlxTGburjTH0rxBI5dOyx7gTn7n2cRAAHPWmTCOON4130_assertion description "[Interestingly, C3 treatment resulted in decreased AR binding to target genes accompanied by decreased recruitment of an AR and ?-catenin cofactor, coactivator-associated arginine methyltransferase 1 (CARM1), providing insight into the unrecognized function of ?-catenin in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1108938.RAwDlxTGburjTH0rxBI5dOyx7gTn7n2cRAAHPWmTCOON4130_provenance.